FDA advisers vote against sleep peptide as they debate safety and health claims
An FDA advisory committee is meeting for two days to discuss whether seven peptides — which have become popular in wellness circles — should be allowed to be compounded.
Access Denied
Access Denied You don’t have permission to access ” on this server. Reference #18.162c1102.1784910568.ece515fd
Boom in tech wealth is fueling record prices for dinosaur bones, art and watches, auction houses say
The major auction houses racked up nearly $10 billion in sales in the first half, marking one of the strongest-ever starts to the year.
American Express rides a boom in Platinum cards to its strongest spending growth in years
Cardmember perks are resonating, an Amex executive says. “It’s really about access.”
Access Denied
Access Denied You don’t have permission to access ” on this server. Reference #18.162c1102.1784884540.e78eea42
The August stock-market slump is a myth — so why does Wall Street keep repeating it?
More than 200 years of data show stocks typically gain in August, while market volatility sits well below average.
Access Denied
Access Denied You don’t have permission to access ” on this server. Reference #18.162c1102.1784871566.e558472d
Most FDA advisers say peptides like BPC-157 and TB-500 should be made available in the U.S. Here’s what happens next.
The FDA is deciding whether seven peptides can be legally compounded, potentially opening the door to broader use in Americans.
As Honda CR-V leads U.S. sales, automaker teases new American-built pickup truck
The future of the Ridgeline midsize pickup truck had been in flux, and the automaker said there will be a temporary production stoppage for the truck.
Access Denied
Access Denied You don’t have permission to access ” on this server. Reference #18.162c1102.1784845878.e293fd1e
